COST-EFFECTIVENESS OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR FOR PATIENTS WITH CHRONIC HCV IN THE NETHERLANDS

被引：1
|
作者：
Gaultney, J. [1 ]
de Knegt, R. J. [2 ]
Fassler, P. [3 ]
Visser, S. [3 ]
Johnson, S. [4 ]
机构：
[1] Mapi Grp, Houten, Netherlands
[2] Erasmus MC, Rotterdam, Netherlands
[3] AbbVie BV, Hoofddorp, Netherlands
[4] Medicus Econ LLC, Milton, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1504
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN71
引用
收藏
页码：A588 / A588
页数：1
相关论文
共 50 条
  • [21] Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection
    Akshanth R. Polepally
    Prajakta S. Badri
    Doerthe Eckert
    Sven Mensing
    Rajeev M. Menon
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 333 - 339
  • [22] THE IMPACT OF OMBITASVIR/PARITAPREVIR/RITONAVIR WITH DASABUVIR IN PATIENTS WITH HCV ASSOCIATED CRYOGLOBULINEMIA- EXPERIENCE OF A SINGLE CENTER
    Iliescu, Elena L.
    Grumeza, Mihaela
    Mercan, Adriana
    Toma, Letitia
    Dodot, Mihai
    Isac, Teodora
    GASTROENTEROLOGY, 2019, 156 (06) : S1232 - S1232
  • [23] Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
    Bernstein, David E.
    Tran, Albert
    Martin, Paul
    Kowdley, Kris V.
    Bourliere, Marc
    Sulkowski, Mark S.
    Pockros, Paul J.
    Renjifo, Boris
    Wang, Deli
    Shuster, Diana L.
    Cohen, Daniel E.
    Jacobson, Ira M.
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (02): : 245 - 256
  • [24] Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection
    Cheng, Elaine Y.
    Saab, Sammy
    Holt, Curtis D.
    Busuttil, Ronald W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (18) : 2835 - 2848
  • [25] All Oral Antiviral Treatment with Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir in Chronic HCV Infection - Real Life Experience
    Iliescu, Laura
    Mercan-Stanciu, Adriana
    Toma, Letitia
    Dodot, Mihai
    Isac, Teodora
    Grumeza, Mihaela
    PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK, 2018, : 138 - 143
  • [26] Effect of Chronic Kidney Disease on the Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir in Subjects with HCV Genotype 1 Infection
    Shuster, Diana L.
    Menon, Rajeev
    Cohen, Daniel E.
    Khatri, Amit
    HEPATOLOGY, 2015, 62 : 744A - 745A
  • [27] Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice
    Revuelta-Herrero, J. L.
    Gimenez-Manzorro, A.
    Matilla-Pena, A.
    Herranz-Alonso, A.
    Sanjurjo-Saez, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (06) : 906 - 909
  • [28] Efficacy and Safety of the Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir Regimen for Chronic Hepatitis C in Hemodialysis Patients
    Tosun, Guven Gurkan
    Sultanova, Fidan
    Nihan, A. K.
    Hizel, Kenan
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2019, 8
  • [29] Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
    Leung, Daniel H.
    Wirth, Stefan
    Yao, Betty B.
    Viani, Rolando M.
    Gonzalez-Peralta, Regino P.
    Jonas, Maureen M.
    Lobritto, Steven J.
    Narkewicz, Michael R.
    Soka, Etienne
    Fortuny, Claudia
    Hsu, Evelyn K.
    Del Valle-Segarra, Antonio
    Zha, Jiuhong
    Larsen, Lois
    Liu, Li
    Shuster, Diana L.
    Cohen, Daniel E.
    Rosenthall, Philip
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (11) : 1311 - 1319
  • [30] Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis
    Pessoa, Mario G.
    Ramalho-Madruga, Jose, V
    Alves, Katia
    Nunes, Estevao P.
    Cheinquer, Hugo
    Brandao-Mello, Carlos E.
    Mendes-Correa, Maria C.
    Ferraz, Maria L.
    Ferreira, Paulo R. A.
    Alvares-da-Silva, Mario R.
    Coelho, Henrique S.
    Affonso-de-Araujo, Evaldo S.
    Furtado, Juvencio
    Parana, Raymundo
    Silva, Giovanni
    Lari, Sara A.
    Liu, Li
    Tripathi, Rakesh
    Pilot-Matias, Tami
    Cohen, Daniel E.
    Shulman, Nancy S.
    Martinelli, Ana
    ANNALS OF HEPATOLOGY, 2018, 17 (06) : 959 - 968
12345